X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
index medicus (39) 39
male (31) 31
oncology (27) 27
aged (22) 22
middle aged (22) 22
cancer (21) 21
prostate cancer (21) 21
chemotherapy (18) 18
clinical trials (17) 17
metastasis (16) 16
docetaxel (15) 15
treatment outcome (14) 14
patients (13) 13
care and treatment (12) 12
research (12) 12
urology & nephrology (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
analysis (10) 10
enzalutamide (10) 10
aged, 80 and over (9) 9
kaplan-meier estimate (9) 9
men (9) 9
survival (9) 9
cabazitaxel (8) 8
prednisone (8) 8
prostatic neoplasms - drug therapy (8) 8
prostatic neoplasms, castration-resistant - drug therapy (8) 8
survival analysis (8) 8
abiraterone (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (7) 7
clinical-trials (7) 7
disease-free survival (7) 7
female (7) 7
journal article (7) 7
medical research (7) 7
metastases (7) 7
mitoxantrone plus prednisone (7) 7
neoplasm staging (7) 7
prostatic neoplasms - pathology (7) 7
radiotherapy (7) 7
randomized controlled trials as topic (7) 7
therapy (7) 7
urology (7) 7
abiraterone acetate (6) 6
adult (6) 6
antineoplastic agents - therapeutic use (6) 6
bladder cancer (6) 6
cancer therapies (6) 6
hematology, oncology and palliative medicine (6) 6
medicine (6) 6
neoplasm metastasis (6) 6
prostate (6) 6
prostate-specific antigen (6) 6
prostatic neoplasms - radiotherapy (6) 6
prostatic neoplasms, castration-resistant - pathology (6) 6
quality of life (6) 6
studies (6) 6
surgery (6) 6
taxoids - administration & dosage (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
article (5) 5
carcinoma (5) 5
castration (5) 5
chemotherapy, adjuvant (5) 5
clinical medicine (5) 5
diagnosis (5) 5
disease progression (5) 5
dk/atira/pure/researchoutput/pubmedpublicationtype/d016428 (5) 5
drug administration schedule (5) 5
increased survival (5) 5
medicine, research & experimental (5) 5
metastatic castration-resistant prostate cancer (5) 5
mitoxantrone (5) 5
patient selection (5) 5
pharmacology (5) 5
prostate-specific antigen - blood (5) 5
prostatic neoplasms - mortality (5) 5
radiation therapy (5) 5
recruitment (5) 5
risk factors (5) 5
taxoids - therapeutic use (5) 5
toxicity (5) 5
urinary bladder neoplasms - pathology (5) 5
urinary bladder neoplasms - surgery (5) 5
zoledronic acid (5) 5
androgen antagonists - administration & dosage (4) 4
androgen antagonists - adverse effects (4) 4
androgens (4) 4
articles (4) 4
attitude of health personnel (4) 4
communication (4) 4
cystectomy - methods (4) 4
diphosphonates - administration & dosage (4) 4
drug therapy (4) 4
external-beam radiotherapy (4) 4
follow-up studies (4) 4
health aspects (4) 4
hospitals (4) 4
imidazoles - administration & dosage (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Summary Background Long-term hormone therapy has been the standard of care for advanced prostate cancer since the 1940s. STAMPEDE is a randomised controlled... 
Internal Medicine | ANDROGEN-DEPRIVATION THERAPY | MEDICINE, GENERAL & INTERNAL | PREDNISONE | DESIGN | MITOXANTRONE | CABAZITAXEL | CLINICAL-TRIALS | OPEN-LABEL | CHEMOTHERAPY | ENZALUTAMIDE | ESTRAMUSTINE | Survival analysis | Medical prognosis | Clinical trials | Hormone replacement therapy | Metastasis | Prostate cancer | Cancer therapies
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1047 - 1060
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 760 - 768
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1605 - 1616
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
The Lancet, ISSN 0140-6736, 12/2018, Volume 392, Issue 10162, pp. 2353 - 2366
Journal Article
by Jepson, Marcus and Elliott, Daisy and Conefrey, Carmel and Wade, Julia and Rooshenas, Leila and Wilson, Caroline and Beard, David and Blazeby, Jane M and Birtle, Alison and Halliday, Alison and Stein, Rob and Donovan, Jenny L and Beard, David and Carr, Andrew and Cook, Jonathan and Cooper, Cushla and Dean, Benjamin and Donovan, Jenny L and Gray, Alastair and Gwilym, Stephen and Judge, Andrew and Merritt, Naomi and Moser, Jane and Rees, Jonathan and Rombach, Ines and Savulescu, Julian and Tracey, Irene and Wartolowska, Karolina and Blazeby, Jane M and Barham, Paul and Brookes, Sara T and Crosby, Tom and Falk, Stephen J and Griffin, S. Michael and Hollingworth, William and Hollowood, Andrew D and Krysztopik, Richard and Lewis, Wyn and Nicklin, Jo and Streets, Christopher and Strong, Sean and Titcomb, Dan and Williams, Geraint and Birtle, Alison and Bryan, Rik and Catto, James and Chester, John and French, Ann and Hall, Emma and Harris, Chris and Johnson, Mark and Jones, Rob and Keeley, Francis and Kirkbank, Tony and Kockelbergh, Roger and Lewis, Rebecca and Newton, Michelle and Powles, Thomas and Waters, Rachel and Winterbottom, Andrew and Halliday, Alison and Becquemin, Jean-Pierre and Belli, Anna and Bosiers, Marc and Cao, Piergiorgio and Davies, Christina and Gough, Michael and Hayter, Elizabeth and Leopold, Peter and McDonald, Sumaira and Michaels, Jonathan and Mihaylova, Borislava and Peto, Richard and Robertson, Steven and Rothwell, Peter and Scott, Rachael and Thomas, Dafydd and Vermassen, Frank and Stein, Rob and Bartlett, John and Cameron, David and Campbell, Amy and Canney, Peter and Dunn, Janet and Earl, Helena and Falzon, Mary and Francis, Adele and Hall, Peter and Harmer, Victoria and Higgins, Helen and Hiller, Louise and Hughes-Davies, Luke and Hulme, Claire and Macpherson, Iain and Makris, Andreas and Marshall, Andrea and McCabe, Christopher and Morgan, Adrienne and Pinder, Sarah and Poole, Christopher and ... and ACST-2 study group and POUT study group and CSAW study group and OPTIMA prelim study group and Chemorad study group and OPTIMA Prelim Study Grp and CSAW Study Grp and Chemorad Study Grp and ACST-2 Study Grp and POUT Study Grp
Journal of Clinical Epidemiology, ISSN 0895-4356, 07/2018, Volume 99, pp. 75 - 83
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 5, pp. 549 - 558
Journal Article